Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Enzo Biochem (ENZ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 335,530
  • Shares Outstanding, K 46,270
  • Annual Sales, $ 102,770 K
  • Annual Income, $ 45,290 K
  • 36-Month Beta 1.46
  • Price/Sales 3.26
  • Price/Book 3.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.86 +24.23%
on 11/09/16
7.29 -0.14%
on 12/07/16
+1.20 (+19.74%)
since 11/07/16
3-Month
4.88 +49.18%
on 09/30/16
7.29 -0.14%
on 12/07/16
+1.65 (+29.31%)
since 09/07/16
52-Week
4.00 +82.00%
on 03/04/16
7.29 -0.14%
on 12/07/16
+2.77 (+61.42%)
since 12/07/15

Most Recent Stories

More News
5 Top Performing Biotechnology Stocks of November

November was a great month for pharma/biotech stocks after a rather difficult year when the industry struggled with media and political focus on high drug prices.

The Zacks Analyst Blog Highlights: Enzo Biochem, Exelixis, Genmab A/S, Heska and Incyte

The Zacks Analyst Blog Highlights: Enzo Biochem, Exelixis, Genmab A/S, Heska and Incyte

Zacks.com featured highlights: include Cambrex, Enzo Biochem, Alliqua BioMedical, CubeSmart and Snap-on

Zacks.com featured highlights: include Cambrex, Enzo Biochem, Alliqua BioMedical, CubeSmart and Snap-on

5 Top Biotech Stocks to Buy on Trump Victory

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House.

Bet on 5 Stocks with Rising P/E to Beat Market Blues

Forget undervalued stocks, play these top-ranked stocks with rising P/E.

Top 5 Stocks with Solid Net Profit Margin

Net profit margin helps investors gain clarity on a company's business model in terms of pricing policy, cost structure and manufacturing efficiency.

Enzo Biochem (ENZ) Looks Good: Stock Adds 11% in Session

Enzo Biochem Inc. (ENZ) moved big last session, as its shares jumped a little more than 11% on the day.

Enzo Biochem Reports Strong 2016 Operating Results

Enzo Biochem Inc. (NYSE:ENZ) today reported strong results for the fourth quarter and fiscal year ended July 31, 2016, paced by revenue growth, margin expansion and litigation successes.

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2016 and Full Year Results Friday, October 14, 2016 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2016 fourth quarter and full year results, Friday, October 14, 2016, at 8:30 AM E.T.

Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay

Enzo Biochem, Inc. (NYSE: ENZ) today announced that the New York State Department of Health has granted conditional approval for use of Enzo Clinical Labs' PLAQPRO(TM) Lp-PLA2 Assay.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Support & Resistance

2nd Resistance Point 7.48
1st Resistance Point 7.38
Last Price 7.28
1st Support Level 7.09
2nd Support Level 6.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.